Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Adenocarcinoma × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 122 Carcinoma, Non-Small-Cell Lung 33 Carcinoma, Renal Cell 29 Neoplasm Metastasis 28 Prostatic Neoplasms 19 Brain Neoplasms 19 Pancreatic Neoplasms 16 Lung Neoplasms 16 Neoplasms 15 Uveal Melanoma 14 Breast Neoplasms 13 Sarcoma 12 Carcinoma, Hepatocellular 12 Skin Neoplasms 10 Kidney Neoplasms 10 Urinary Bladder Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Triple Negative Breast Neoplasms 7 Small Cell Lung Carcinoma 7 Ovarian Neoplasms 7 Glioblastoma 7 Colorectal Neoplasms 7 Colonic Neoplasms 7 Recurrence 6 Multiple Myeloma 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Clear-cell metastatic renal cell carcinoma 6 Carcinoma, Transitional Cell 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5

Interventions

Gemcitabine 8 Albumin-Bound Paclitaxel 6 Taxes 4 Radiotherapy, Intensity-Modulated 3 130-nm albumin-bound paclitaxel 3 Radiotherapy 2 Fluorouracil 2 niraparib 1 irinotecan sucrosofate 1 folfirinox 1 durvalumab 1 dehydroftorafur 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Panitumumab 1 Oxaliplatin 1 Optical Imaging 1 Nivolumab 1 Metformin 1 Losartan 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Interleukin 1 Receptor Antagonist Protein 1 Folfox protocol 1 Ethiodized Oil 1 Electronic Health Records 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03404960 2025-10-10

Parpvax

University of Pennsylvania

Phase 1/2 Completed

104 enrolled 11 charts

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡